๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The immunotherapy of prostate and bladder cancer

โœ Scribed by Thomas H. Totterman; Angelica Loskog; Magnus Essand


Book ID
109052037
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
152 KB
Volume
96
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Immunotherapy of bladder cancer
โœ Unyime O. Nseyo; Donald L. Lamm ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 48 KB ๐Ÿ‘ 2 views

Intravesical therapy has been used in the management of superficial transitional cell carcinoma (TCC) of the urinary bladder (i.e., Ta, Tl, and carcinoma in situ) with specific objectives which include treating existing/residual tumor, preventing recurrence of tumor, preventing disease progression,

The immunotherapy of prostate cancer
โœ Dalgleish, A G; Perry, M J A; Eaton, J D; Hrouda, D; Todryk, S M; Kirby, R S ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 96 KB
Immunotherapy of prostate cancer
โœ Stephen J. Freedland; Allan J. Pantuck; Jeffrey Weider; Amnon Zisman; Arie S. Be ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Springer ๐ŸŒ English โš– 267 KB
Immunotherapy with dendritic cells for p
โœ Anna-Katharina Thomas-Kaskel; Cornelius F. Waller; Wolfgang Schultze-Seemann; He ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 152 KB

## Abstract Radical prostatectomy for prostate cancer is followed by PSA recurrence in up to 40% of patients. One third of patients with biochemical relapse progress to uncurable metastatic disease. Therefore, alternative treatment modalities are needed both in the situation of PSA recurrence and i